CSPAN3 FDA Transparency - Panel 2 - Investors January 17, 2018
The company focuses on Venture Capital and structured investments and Bio Technology and pharmaceuticals. Prior for 16 years he led the firms in investment in Bio Technology and pharmaceuticals. Hes been active in policy discussions, served on the executive committee on the board of national Venture Capital association and led that groups Life Sciences efforts. Hes also served on the emerging Company Section board on the Bio Technology board industry organization. Hes served on many nonprofit boards. He is a graduate of Harvard University and the Stanford School of business. And we really appr...